Bio Green Med Solution, Inc. (BGMSP) Financial Statements (2026 and earlier)

Company Profile

Business Address 200 CONNELL DRIVE
BERKELEY HEIGHTS, NJ 07922
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3,5053,1373,37818,34536,55933,406
Cash and cash equivalent3,5053,1373,37818,34536,55933,406
Receivables1,257     
Inventory, net of allowances, customer advances and progress billings1,384     
Inventory1,384     
Prepaid expense110     
Other current assets  3003414267966
Other undisclosed current assets  2373,7255,6404,3041,997
Total current assets:6,2563,6747,44424,41140,94235,469
Noncurrent Assets
Operating lease, right-of-use asset12593142301,227
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization137393264106
Intangible asset, including goodwill, after accumulated amortization1,570     
Goodwill1,570     
Deposits noncurrent assets 4121,2592,9161,551 
Other undisclosed noncurrent assets 210     
Total noncurrent assets:1,9294201,3613,0901,6451,333
TOTAL ASSETS:8,1854,0948,80527,50142,58736,802
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,3326,2688,1617,3925,2942,486
Accounts payable6174,5993,5432,5612,117514
Accrued liabilities7151,6694,6184,8313,1771,972
Total current liabilities:1,3326,2688,1617,3925,2942,486
Noncurrent Liabilities
Long-term debt and lease obligation:     301,057
Liabilities, other than long-term debt 2 37106  
Operating lease, liability 2 37106301,057
Other undisclosed noncurrent liabilities9   (30) 
Total noncurrent liabilities:11 37106301,057
Total liabilities:1,3436,2688,1987,4985,3243,543
Temporary equity, including noncontrolling interest    4,494  
Equity
Equity, attributable to parent6,842(2,174)60715,50937,26333,259
Common stock5919106
Additional paid in capital461,287438,202429,796422,973422,960400,071
Accumulated other comprehensive loss(39)(891)(908)(1,316)(748)(746)
Accumulated deficit(454,411)(439,494)(428,282)(406,157)(384,959)(366,072)
Total equity:6,842(2,174)60715,50937,26333,259
TOTAL LIABILITIES AND EQUITY:8,1854,0948,80527,50142,58736,802

Income Statement (P&L) ($ in thousands)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues74743420   
Gross profit:74743420   
Operating expenses(9,174)(12,047)(25,873)(27,656)(22,938)(10,636)
Other undisclosed operating income      
Operating loss:(8,427)(12,004)(25,453)(27,656)(22,938)(10,636)
Nonoperating income (expense)5,43610(98)1,741204955
Investment income, nonoperating 4,947122662101642
Gain (loss), foreign currency transaction, before tax73(54)(414)2334422
Other nonoperating income35452501,298144891
Loss from continuing operations before income taxes:(2,991)(11,994)(25,551)(25,915)(22,734)(9,681)
Income tax expense (benefit)(7)7822,9964,7173,8471,236
Loss from continuing operations:(2,998)